Visceral leishmaniasis: Very rare cases report from Kashmir valley (J&K) with Literature Review
暂无分享,去创建一个
[1] M. Armstrong,et al. Epidemiology of imported cutaneous leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: use of polymerase chain reaction to identify the species. , 2012, American Journal of Tropical Medicine and Hygiene.
[2] Shyam Sundar,et al. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. , 2010, The New England journal of medicine.
[3] P. Gershkovich,et al. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis. , 2009, The Journal of infectious diseases.
[4] S. Sundar,et al. Cost‐effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India , 2009, Tropical medicine & international health : TM & IH.
[5] D. Singh,et al. Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by rK39 Testing of Sputum Samples , 2009, Journal of Clinical Microbiology.
[6] G. Schönian,et al. PCR diagnosis of visceral leishmaniasis in an endemic region, Mymensingh district, Bangladesh , 2009, Tropical medicine & international health : TM & IH.
[7] C. Rizzo,et al. Recombinant K39 immunochromatographic test for diagnosis of human leishmaniasis. , 2009, Future microbiology.
[8] Joshua D. Hartzell,et al. Positive rK39 serologic assay results in US servicemen with cutaneous leishmaniasis. , 2008, The American journal of tropical medicine and hygiene.
[9] A. Descoteaux,et al. Leishmania invasion and phagosome biogenesis. , 2008, Sub-cellular biochemistry.
[10] S. Sundar,et al. Oral miltefosine for the treatment of Indian visceral leishmaniasis. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[11] G. Wortmann,et al. Rapid identification of Leishmania complexes by a real-time PCR assay. , 2005, The American journal of tropical medicine and hygiene.
[12] P. Holzmuller,et al. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. , 2005, Vaccine.
[13] K. Fragaki,et al. Recombinant DNA-derived leishmania proteins: from the laboratory to the field. , 2005, The Lancet. Infectious diseases.
[14] R. Prasad,et al. Miltefosine: An oral drug for visceral leishmaniasis , 2004, Indian journal of pediatrics.
[15] M. Rai,et al. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. , 2001, BMJ : British Medical Journal.
[16] L. Gradoni,et al. Diffuse necrotic hepatic lesions due to visceral leishmaniasis in AIDS. , 1998, The Journal of infection.
[17] R. Pearson,et al. Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion. , 1993, Chest.
[18] R. Pearson,et al. The Leishmania. Protozoans adapted for extracellular and intracellular survival. , 1992, Sub-cellular biochemistry.
[19] E. Carvalho,et al. Renal involvement in visceral leishmaniasis. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] A. Bryceson,et al. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. , 1983, The American journal of tropical medicine and hygiene.
[21] R. Pulvertaft,et al. Stages in the life-cycle of Leishmania donovani. , 1960, Transactions of the Royal Society of Tropical Medicine and Hygiene.